127 related articles for article (PubMed ID: 21455211)
1. Nondividing cells: a safer bet for integrating vectors?
Brady T; Bushman FD
Mol Ther; 2011 Apr; 19(4):640-1. PubMed ID: 21455211
[No Abstract] [Full Text] [Related]
2. Lentiviral vector integration profiles differ in rodent postmitotic tissues.
Bartholomae CC; Arens A; Balaggan KS; Yáñez-Muñoz RJ; Montini E; Howe SJ; Paruzynski A; Korn B; Appelt JU; Macneil A; Cesana D; Abel U; Glimm H; Naldini L; Ali RR; Thrasher AJ; von Kalle C; Schmidt M
Mol Ther; 2011 Apr; 19(4):703-10. PubMed ID: 21364536
[TBL] [Abstract][Full Text] [Related]
3. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector.
Kantor B; Bayer M; Ma H; Samulski J; Li C; McCown T; Kafri T
Mol Ther; 2011 Mar; 19(3):547-56. PubMed ID: 21157436
[TBL] [Abstract][Full Text] [Related]
4. Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.
Takayama K; Torashima T
J Neurovirol; 2009 Sep; 15(5-6):371-9. PubMed ID: 19739019
[TBL] [Abstract][Full Text] [Related]
5. Self-inactivating lentiviral vectors with U3 and U5 modifications.
Iwakuma T; Cui Y; Chang LJ
Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
[TBL] [Abstract][Full Text] [Related]
6. Host factors for retroviral integration site selection.
Debyser Z; Christ F; De Rijck J; Gijsbers R
Trends Biochem Sci; 2015 Feb; 40(2):108-16. PubMed ID: 25555456
[TBL] [Abstract][Full Text] [Related]
7. Understanding lentiviral vector chromatin targeting: working to reduce insertional mutagenic potential for gene therapy.
Papayannakos C; Daniel R
Gene Ther; 2013 Jun; 20(6):581-8. PubMed ID: 23171920
[TBL] [Abstract][Full Text] [Related]
8. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.
Schambach A; Galla M; Maetzig T; Loew R; Baum C
Mol Ther; 2007 Jun; 15(6):1167-73. PubMed ID: 17406345
[TBL] [Abstract][Full Text] [Related]
9. Differences in vector-genome processing and illegitimate integration of non-integrating lentiviral vectors.
Shaw AM; Joseph GL; Jasti AC; Sastry-Dent L; Witting S; Cornetta K
Gene Ther; 2017 Jan; 24(1):12-20. PubMed ID: 27682478
[TBL] [Abstract][Full Text] [Related]
10. Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to moloney murine leukemia virus-based vectors.
Barrette S; Douglas JL; Seidel NE; Bodine DM
Blood; 2000 Nov; 96(10):3385-91. PubMed ID: 11071632
[TBL] [Abstract][Full Text] [Related]
11. Hybrid lentivirus-transposon vectors with a random integration profile in human cells.
Staunstrup NH; Moldt B; Mátés L; Villesen P; Jakobsen M; Ivics Z; Izsvák Z; Mikkelsen JG
Mol Ther; 2009 Jul; 17(7):1205-14. PubMed ID: 19240688
[TBL] [Abstract][Full Text] [Related]
12. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
13. [Approaches towards directed DNA integration by the use of retroviral integrases and transposases].
Kniazhanskaia ES; Kondrashina OV; Gottikh MB
Mol Biol (Mosk); 2011; 45(6):931-48. PubMed ID: 22295563
[TBL] [Abstract][Full Text] [Related]
14. Targeted integration by adeno-associated virus.
Weitzman MD; Young SM; Cathomen T; Samulski RJ
Methods Mol Med; 2003; 76():201-19. PubMed ID: 12526165
[No Abstract] [Full Text] [Related]
15. 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors.
Manic G; Maurin-Marlin A; Galluzzi L; Subra F; Mouscadet JF; Bury-Moné S
Hum Gene Ther Methods; 2012 Apr; 23(2):84-97. PubMed ID: 22456436
[TBL] [Abstract][Full Text] [Related]
16. Dotting the I's and crossing the T's: integration analyses in transduced patient T cells.
Rossi JJ
Mol Ther; 2009 May; 17(5):756-7. PubMed ID: 19404325
[No Abstract] [Full Text] [Related]
17. Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples.
Schmidt M; Hoffmann G; Wissler M; Lemke N; Müssig A; Glimm H; Williams DA; Ragg S; Hesemann CU; von Kalle C
Hum Gene Ther; 2001 May; 12(7):743-9. PubMed ID: 11339891
[TBL] [Abstract][Full Text] [Related]
18. Disclosing the Parameters Leading to High Productivity of Retroviral Producer Cells Lines: Evaluating Random Versus Targeted Integration.
Bandeira VS; Tomás HA; Alici E; Carrondo MJ; Coroadinha AS
Hum Gene Ther Methods; 2017 Apr; 28(2):78-90. PubMed ID: 28301970
[TBL] [Abstract][Full Text] [Related]
19. Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector.
Chumakov SP; Kravchenko JE; Prassolov VS; Frolova EI; Chumakov PM
Plasmid; 2010 May; 63(3):143-9. PubMed ID: 20064551
[TBL] [Abstract][Full Text] [Related]
20. Comparative clonal analysis of reconstitution kinetics after transplantation of hematopoietic stem cells gene marked with a lentiviral SIN or a γ-retroviral LTR vector.
Cornils K; Bartholomae CC; Thielecke L; Lange C; Arens A; Glauche I; Mock U; Riecken K; Gerdes S; von Kalle C; Schmidt M; Roeder I; Fehse B
Exp Hematol; 2013 Jan; 41(1):28-38.e3. PubMed ID: 22989760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
